M. Milone

Oncology · 2009–2018

A researcher in the Science corpus: 8 papers; trusts 1 researcher and is trusted by 1 researcher here, as inferred from the citation graph.

Subfields

Whom M. Milone trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. C. June

Who trusts M. Milone overall

  1. D. Porter
  2. C. June
  3. S. Maude

Papers from M. Milone's perspective

Ordered by how strongly the researchers M. Milone trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Chimeric Antigen Receptor–Modified T Cells in Chronic Lymphoid Leukemia (New England Journal of Medicine)
  2. Chimeric antigen receptor T cells persist and induce sustained remissions in relapsed refractory chronic lymphocytic leukemia (Science Translational Medicine)
  3. A Phase I Study on Adoptive Immunotherapy Using Gene-Modified T Cells for Ovarian Cancer (Clinical Cancer Research)
  4. Targeted therapy with the T-cell-engaging antibody blinatumomab of chemotherapy-refractory minimal residual disease in B-lineage acute lymphoblastic leukemia patients results in high response rate… (Journal of Clinical Oncology)
  5. Chimeric Antigen Receptor T Cells for Sustained Remissions in Leukemia (New England Journal of Medicine)
  6. HER2-Specific Chimeric Antigen Receptor–Modified Virus-Specific T Cells for Progressive Glioblastoma (JAMA Oncology)
  7. Transfusion independence and HMGA2 activation after gene therapy of human β-thalassaemia (Nature)
  8. 4-1BB Costimulation Ameliorates T Cell Exhaustion Induced by Tonic Signaling of Chimeric Antigen Receptors (Nature Medicine)
  9. Mesothelin-specific Chimeric Antigen Receptor mRNA-Engineered T cells Induce Anti-Tumor Activity in Solid Malignancies (Cancer immunology research)
  10. A Programmable Dual-RNA–Guided DNA Endonuclease in Adaptive Bacterial Immunity

Their papers